Stifel Nicolaus Downgrades Auxilium Pharmaceuticals To Hold, Shares Drop

Analysts at Stifel Nicolaus downgraded Auxilium Pharmaceuticals AUXL from Buy to Hold and removed the price target of $30.00. Auxilium Pharmaceuticals shares have surged 65.64% over the past 52 weeks, while the S&P 500 index has gained 18.13% in the same period. Auxilium Pharmaceuticals' shares dropped 1.41% to $30.70 in pre-market trading.